Neurocrine Biosciences has handed back two discovery-stage gene therapy programs to Voyager Therapeutics, although the companies’ wider central-nervous-system-focused collaboration remains on track.

Dyno-ahq is optimized for widespread and efficient delivery to the brain and throughout the CNS upon IV injection. With enhanced CNS delivery efficiencies compared to prior Dyno capsids ...

Meeting the demand for clinically relevant neurodegenerative treatments requires a paradigm shift in how central nervous system (CNS) clinical trials have been designed and executed. Four years ...

The antitumour response we uncovered in the leptomeninges raises the possibility that other immune responses there might diverge from their typical behaviour outside the central nervous system.

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

v. Avadel CNS Pharma., 2025 WL 1298920, — F.4 th — (Fed. Cir. May 6, 2025), addressed the scope of the 35 U.S.C. § 271(e)(1) “safe harbor” provisions for certain clinical trials and ...

Introduction: Primary central nervous system vasculitis (PCNSV) is a rare inflammatory arteriopathy confined to the brain, spinal cord, and leptomeninges. Because of its nonspecific presentation ...

Its preclinical candidate ATV:aSyn is a bispecific antibody designed to penetrate the central nervous system more effectively, with one end targeting alpha-synuclein and another targeting a ...

The central nervous system consists of the brain and spinal cord, while the peripheral nervous system consists of the nerves that branch out from these areas and into other parts of the body.

Lars Nico Deutz, B.S. Neuroscience, Honors Program, High Honors, Special Departmental Honors in Neuroscience, Distinction in Research (12:00 PM ceremony) Sami Farooqui, B.S. Public Health, High Honors ...